scispace - formally typeset
O

Osamu Matsubara

Researcher at National Defense Medical College

Publications -  136
Citations -  9108

Osamu Matsubara is an academic researcher from National Defense Medical College. The author has contributed to research in topics: Carcinoma & Adenocarcinoma. The author has an hindex of 42, co-authored 135 publications receiving 8511 citations. Previous affiliations of Osamu Matsubara include Vanderbilt University & Japanese Foundation for Cancer Research.

Papers
More filters
Journal ArticleDOI

American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias

TL;DR: The Diagnostic Process Is Dynamic Clinical Evaluation Radiological Evaluation Role of Surgical Lung Biopsy Unclassifiable Interstitial Pneumonia Bronchoalveolar Lavage Fluid Evaluation Idiopathic Pulmonary Fibrosis.
Journal ArticleDOI

The correlation between cytoplasmic overexpression of epidermal growth factor receptor and tumor aggressiveness: poor prognosis in patients with pancreatic ductal adenocarcinoma.

TL;DR: It is suggested that the cytoplasmic overexpression of EGFr plays a significant role in the progression of pancreatic ductal adenocarcinoma, especially in the invasion and acquisition of aggressive clinical behavior.
Journal Article

Identification and Characterization of Genes Associated with Human Hepatocellular Carcinogenesis

TL;DR: Eight cDNAs encoding galectin 4 (Gal-4), UGT2B4 (UDP-glucuronosyltransferase), ribosomal phosphoprotein P0 (rpP0), dek, insulin-like growth factor binding protein (IGFBP) 1, vitronectin, retinoic acid-induced gene E (RIG-E), and CYP3A4 (cytochrome P450 nifedipine oxid
Journal ArticleDOI

Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations.

TL;DR: The results suggest that loss of ARID1A protein expression occurs as a very early event in ovarian clear-cell carcinoma development, similar to the pattern of PIK3CA mutation recently reported by the group, and frequently coexists (not mutually exclusive) with Pik3CA mutations.